Objective: Determining the clinical efficacy and cost-effectiveness of the Masquelet (Arm I) versus the CTMC technique (Arm II) in combination with reamer-irrigator-aspirator (RIA) harvested autograft (Option A) or allograft-demineralized bone matrix (DBM) composite (Option II) in the treatment of segmental long bone deficiencies.